Development of fully automated determination of marker-specific immunoglobulin G (IgG) avidity based on the avidity competition assay format: Application for abbott architect cytomegalovirus and toxo IgG avidity assays

Journal of Clinical Microbiology

Volumn 47, Issue 3, 2009, Pages 603-613

  Curdt, Ingo ^a   Praast, Gerald ^a   Sickinger, Eva ^a   Schultess, Jan ^a   Herold, Iris ^a   Braun, Hans Bertram ^a   Bernhardt, Stephanie ^a   Maine, Gregory T ^b   Smith, Darwin D ^b   Hsu, Stephen ^b   Christ, Heike M ^a   Pucci, Dominick ^b   Hausmann, Michael ^a   Herzogenrath, Jörg ^a  

^a ABBOTT GMBH AND CO KG   (Germany)

^b ABBOTT DIAGNOSTICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMALE; HUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; TOXOPLASMA GONDII; VIRUS CULTURE; VIRUS STRAIN;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; AUTOMATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; SENSITIVITY AND SPECIFICITY; TOXOPLASMA; TOXOPLASMOSIS;

CYTOMEGALOVIRUS; TOXOPLASMA GONDII;

EID: 62749168361     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01076-08     Document Type: Article

References (29)

1. Blackburn, N. K., T. G. Besselaar, B. D. Schoub, and K. F. O'Connell. 1991. Differentiation of primary cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity. J. Med. Virol. 33:6-9.
2. Candolfi, E., R. Pastor, R. Huber, D. Filisetti, and O. Villard. 2007. IgG avidity assay firms up the diagnosis of acute toxoplasmosis on the first serum sample in immunocompetent pregnant women. Diagn. Microbiol. Infect. Dis. 58:83-88.
3. Dangel, V., U. Bader, and G. Enders. 2006. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples. J. Clin. Virol. 35:303-309.
4. Friguet, B., A. F. Chaffotte, L. Djavadi-Ohaniance, and M. E. Goldberg. 1985. Measurements of the true affinity constant in solution by antigen-antibody complexes by enzyme-linked immunosorbent assay. J. Immunol. Methods 77:305-319.
5. Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual, p. 23-52. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
6. Hedman, K., M. Lappalainen, I. Seppälä, and O. Mäkelä. 1989. Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J. Infect. Dis. 159:736-740.
7. Hedman, K., M. Lappalainen, M. Söderlund, and L. Hedman. 1993. Avidity of IgG in serodiagnosis of infectious diseases. Rev. Med. Microbiol. 4:123-129.
8. Horváth, K. N., Z. Szénási, J. Danka, and I. Kucsera. 2005. Value of the IgG avidity in the diagnosis of recent toxoplasmosis: a comparative study of four commercially available anti-Toxoplasma gondii IgG avidity assays. Acta Parasitol. 50:255-260.
9. Inouye, S., A. Hasegawa, S. Matsuno, and S. Katow. 1984. Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturing agent is employed. J. Clin. Microbiol. 20:525-529.
10. Kamoun, P. P. 1988. Denaturation of globular proteins by urea: breakdown of hydrogen or hydrophobic bonds? Trends Biochem. Sci. 13:424-425.
11. Kangro, H. O., S. Manzoor, and D. R. Harper. 1991. Antibody avidity following varicella-zoster virus infections. J. Med. Virol. 33:100-105.
12. Kneitz, R. H., J. Schubert, F. Tollmann, W. Zens, K. Hedman, and B. Weissbrich. 2004. A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid. BMC Infect. Dis. 4:33.
13. Lazzarotto, T., B. Guerra, M. Lanari, L. Gabrielli, and M. P. Landini. 2008. New advances in the diagnosis of congenital cytomegalovirus infection. J. Clin. Virol. 41:192-197.
14. Lazzarotto, T., C. Galli, R. Pulvirenti, R. Rescaldani, R. Vezzo, A. La Gioia, C. Martinelli, S. La Rocca, G. Agresti, L. Grillner, M. Nordin, M. van Ranst, B. Combs, G. T. Maine, and M. P. Landini. 2001. Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay. Clin. Diagn. Lab. Immunol. 8:196-198.
15. Montoya, J. G., O. Liesenfeld, S. Kinney, C. Press, and J. S. Remington. 2002. VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women. J. Clin. Microbiol. 40:2504-2508.
16. Petersen, E., M. V. Borobio, E. Guy, O. Liesenfeld, V. Meroni, A. Naessens, E. Spranzi, and P. Thulliez. 2005. European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index. J. Clin. Microbiol. 43:1570-1574.
17. Polanec, J., I. Seppala, S. Rousseau, and K. Hedman. 1994. Evaluation of protein-denaturing immunoassays for avidity of immunoglobulin G to rubella virus. J. Clin. Lab. Anal. 8:16-21.
18. Press, C., J. G. Montoya, and J. S. Remington. 2005. Use of a single serum sample for diagnosis of acute toxoplasmosis in pregnant women and other adults. J. Clin. Microbiol. 43:3481-3483.
19. Pullen, G. R., M. G. Fitzgerald, and C. S. Hosking. 1986. Antibody avidity determination by ELISA using thiocyanate elution. J. Immunol. Methods 86:83-87.
20. Quinn, F. A. 2001. Bulk reagent random-access analyzer: ARCHITECT I 2000, p. 363-367. In D. Wild (ed.), The immunoassay handbook, 2nd ed. Nature Publishing Group, London, England.
21. Revello, M. G., G. Gorini, and G. Gerna. 2004. Clinical evaluation of a chemiluminescence immunoassay for determination of immunoglobulin G avidity to human cytomegalovirus. Clin. Diagn. Lab. Immunol. 11:801-805.
22. Roque-Afonso, A. M., L. Grangeot-Keros, B. Roquebert, D. Desbois, J. D. Poveda, V. Mackiewicz, and E. Dussaix. 2004. Diagnostic relevance of immunoglobulin G avidity for hepatitis A virus. J. Clin. Microbiol. 42:5121-5124.
23. Scatchard, G. 1949. The attractions of proteins for small molecules and ions. Ann. N. Y. Acad. Sci. 51:660-672.
24. Sickinger, E., F. Gay-Andrieu, G. Jonas, J. Schultess, M. Stieler, D. Smith, M. Hausmann, R. Stricker, R. Stricker, J. Dhein, and H.-B. Braun. 2008. Performance characteristics of the new ARCHITECT Toxo IgG and Toxo IgG avidity assays. Diagn. Microbiol. Infect. Dis. 62:235-244.
25. Suligoi, B., C. Galli, M. Massi, F. Di Sora, M. Sciandra, P. Pezzotti, O. Recchia, F. Montella, A. Sinicco, and G. Rezza. 2002. Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. J. Clin. Microbiol. 40:4015-4020.
26. Thomas, H. I. 1997. Relative functional affinity of specific anti-core IgG in different categories of hepatitis B virus infection. J. Med. Virol. 51:189-197.
27. Ward, K. N., W. Dhaliwal, K. L. Ashworth, E. J. Clutterbuck, and C. G. Teo. 1994. Measurement of antibody avidity for hepatitis C virus distinguishes primary antibody responses from passively acquired antibody. J. Med. Virol. 43:367-372.
28. Weissbrich, B. 1998. The use of semi-automated EBV IgG avidity determination for the diagnosis of infectious mononucleosis. J. Med. Virol. 54:145-153.
29. Zhang, J. Z., S. W. Im, S. H. Lau, T. N. Chau, S. T. Lai, S. P. Ng, M. Peiris, C. Tse, T. K. Ng, and M. H. Ng. 2002. Occurrence of hepatitis E virus IgM, low avidity IgG serum antibodies, and viremia in sporadic cases of non-A, -B, and -C acute hepatitis. J. Med. Virol. 66:40-48.